Voyager Therapeutics (VYGR) Cash from Investing Activities Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 116.52% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 38.24% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -22.09% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 30.54% |
| 10 | Voyager Therapeutics | 230.25 Mn | 88.77 Mn | - | -17.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.62% |
| Dec 31, 2025 | 49.95% |
| Sep 30, 2025 | 0.16% |
| Jun 30, 2025 | 27.11% |
| Mar 31, 2025 | 59.53% |
| Dec 31, 2024 | -70.75% |
| Sep 30, 2024 | 64.94% |
| Jun 30, 2024 | -53.32% |
| Mar 31, 2024 | -68.39% |
| Dec 31, 2023 | 48.08% |
| Sep 30, 2023 | -98.21% |
| Jun 30, 2023 | -137.63% |
| Mar 31, 2023 | -48.96% |
| Dec 31, 2022 | -18.99% |
| Sep 30, 2022 | 15.37% |
| Jun 30, 2022 | -132.14% |
| Mar 31, 2022 | 47.30% |
| Dec 31, 2021 | -29.88% |
| Sep 30, 2021 | 141.13% |
| Jun 30, 2021 | 33.46% |
| Mar 31, 2021 | -15.99% |
| Dec 31, 2020 | 28.99% |
| Sep 30, 2020 | 128.20% |
| Jun 30, 2020 | -26.99% |
| Mar 31, 2020 | 74.10% |
| Dec 31, 2019 | 57.79% |
| Sep 30, 2019 | 50.66% |
| Jun 30, 2019 | -27.39% |
| Mar 31, 2019 | -137.07% |
| Dec 31, 2018 | 31.76% |
| Sep 30, 2018 | 51.59% |
| Jun 30, 2018 | 11.11% |
| Mar 31, 2018 | 631.45% |
| Dec 31, 2017 | -290.54% |